Press release
๐๐ซ๐๐๐ญ๐ฆ๐๐ง๐ญ-๐๐๐ฌ๐ข๐ฌ๐ญ๐๐ง๐ญ ๐๐๐ฉ๐ซ๐๐ฌ๐ฌ๐ข๐จ๐ง ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฉ๐จ๐ซ๐ญ, ๐๐ข๐ณ๐, ๐๐ก๐๐ซ๐ & ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค - ๐๐๐๐-
๐๐ซ๐๐๐ญ๐ฆ๐๐ง๐ญ-๐๐๐ฌ๐ข๐ฌ๐ญ๐๐ง๐ญ ๐๐๐ฉ๐ซ๐๐ฌ๐ฌ๐ข๐จ๐ง ๐๐๐ซ๐ค๐๐ญ || 2024-2031
Treatment-Resistant Depression (TRD) refers to a form of major depressive disorder (MDD) in which patients do not respond adequately to standard treatments, such as antidepressants or psychotherapy. Typically, a person is considered to have TRD when they have tried at least two different antidepressant medications, each for an adequate duration and dosage, without experiencing significant improvement in their symptoms. This condition requires more intensive treatment strategies, which may include a combination of medications, electroconvulsive therapy (ECT), or newer treatments like transcranial magnetic stimulation (TMS) or ketamine therapy.
Get a Free Sample Research PDF - https://www.datamintelligence.com/download-sample/treatment-resistant-depression-market
Key Developments:
โ August 19, 2022: The U.S. FDA approved AUVELITYโข (dextromethorphan HBr-bupropion HCl) extended-release tablets for the treatment of major depressive disorder (MDD) in adults.
โข Developed by Axsome Therapeutics, Inc., a biopharmaceutical company focused on therapies for central nervous system (CNS) disorders.
โ January 30, 2023: Otsuka Pharmaceutical Co., Ltd. submitted a Japanese application for Rexulti (brexpiprazole) as an adjunct therapy for MDD and depressive states.
โข This application is limited to patients who have not responded well to prior antidepressant therapy.
โข A phase 3 clinical trial involving 740 adult MDD patients in Japan (ages 20-64) demonstrated the safety and efficacy of brexpiprazole as an additional treatment.
Market Dynamics:
โ Developed economies have seen rapid growth in healthcare sectors due to high investments, income levels, and infrastructure development.
โ Rising cases of treatment-resistant depression (TRD) are linked to increased lung cancer cases in some regions.
โ Collaborations, acquisitions, and product launches with technological advancements are key drivers of market growth.
Market Segmentation:
By Drugs: Antipsychotics (Aripiprazole (Abilify), Brexpiprazole (Rexulti), Quetiapine (Seroquel), Olanzapine (Zyprexa), Selective Serotonin Reuptake Inhibitors (SSRIs) (Fluoxetine (Prozac), Sertraline (Zoloft), Citalopram (Celexa), Paroxetine (Paxil), Serotonin and Noradrenaline Reuptake Inhibitors (SNRIs) (Duloxetine (Cymbalta), Venlafaxine (Effexor XR), Desvenlafaxine (Pristiq), Monoamine Oxidase Inhibitors (MAOIs) (Phenelzine (Nardil), Isocarboxazid (Marplan), Others.
By Route of Administration: Oral, Injectable, Others.
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.
Get Customized Report: https://www.datamintelligence.com/customize/treatment-resistant-depression-market
Major Key Players:
โข Pfizer Inc.
โข Viatris Inc.
โข Novartis AG
โข AbbVie Inc.
โข Eli Lilly and Company
โข Otsuka America Pharmaceutical, Inc.
โข AstraZeneca
โข Camber Pharmaceuticals, Inc.
โข Biodesix
โข Validus Pharmaceuticals
*Note:
โข Additionally, I wanted to highlight that the full version of the report includes an in-depth analysis of emerging players and startups, which will provide valuable insights into the evolving market landscape and key strategies being adopted.
Related Reports:
Psychedelic Drugs Market: https://datamintelligence.com/research-report/psychedelic-drugs-market
Psychotherapeutic Drugs Market: https://datamintelligence.com/research-report/psychotherapeutic-drugs-market
Affiliate Marketing Request here: https://www.datamintelligence.com/affiliate-marketing
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release ๐๐ซ๐๐๐ญ๐ฆ๐๐ง๐ญ-๐๐๐ฌ๐ข๐ฌ๐ญ๐๐ง๐ญ ๐๐๐ฉ๐ซ๐๐ฌ๐ฌ๐ข๐จ๐ง ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฉ๐จ๐ซ๐ญ, ๐๐ข๐ณ๐, ๐๐ก๐๐ซ๐ & ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค - ๐๐๐๐- here
News-ID: 3656756 • Views: โฆ
More Releases from DataM Intelligence 4market Research LLP
North America Surgical LED Lights Market Growth Outlook 2024-2031 | Top Companie โฆ
The North America Surgical Led Lights market was reached at a high CAGR from 2024 to 2031.
Surgical LED Lights are specialized lighting devices used in operating rooms and surgical settings to provide bright, focused illumination during surgical procedures. These lights utilize Light Emitting Diode (LED) technology, which offers several advantages over traditional lighting sources, including improved energy efficiency, reduced heat generation, and longer lifespans. Surgical LED lights can be adjustedโฆ
Respiratory Monitoring Devices Market to Reach US$38.14 Billion by 2033 at 8.2% โฆ
The global respiratory monitoring devices market size was US$ 18.80 Billion in 2024 and is expected to reach US$ 38.14 Billion by 2033, growing at a CAGR of 8.2% from 2025 to 2033. as healthcare providers increase adoption of advanced monitoring solutions to improve diagnosis, management, and care of respiratory conditions.
Growth is supported by rising demand across key product types such as wearable sensors, capnography systems, spirometers, andโฆ
Heart Implant Monitor Market: Comprehensive Industry Analysis, Trends, and Futur โฆ
The global Heart Implant Monitor Market, also known as the implantable cardiac monitor (ICM) or insertable cardiac monitor market, represents a rapidly evolving segment within the broader cardiac diagnostics industry. These devices are small, minimally invasive monitors implanted under the skin to continuously track heart rhythm abnormalities over extended periods. They play a critical role in detecting arrhythmias, unexplained syncope, atrial fibrillation (AF), and cryptogenic stroke.
With cardiovascular diseases (CVDs) remainingโฆ
Cardiac Catheters and Guidewires Market to Reach US$64.09 Billion by 2033 at 7.7 โฆ
The cardiac catheters and guidewires was valued at US$ 14.53 Billion. The global Cardiac Catheters and Guidewires market size reached US$ 15.54 Billion in 2024 and is expected to reach US$ 64.09 Billion by 2033, growing at a CAGR of 7.7% from 2025-2033. as the global burden of cardiovascular diseases rises and minimally invasive interventional procedures become more widely adopted.
Growth is supported by increasing demand across key product types suchโฆ
More Releases for MDD
Consolidating Office Armchair Market Presence: Key Tactics Deployed by Industry โฆ
"The authors of this comprehensive report have conducted an extensive study of the global Office Armchair market, placing significant emphasis on various critical aspects. Their research delves deeply into the vendor landscape, regional expansion, leading market segments, emerging trends, key opportunities, and other pivotal subjects. The report not only underscores influential factors driving demand in the global Office Armchair market but also identifies factors that might hinder its growth. Itโฆ
Global Depression-MDD Drugs Market Analysis By Major Manufacturers and Competiti โฆ
Global Depression-MDD Drugs Market: Driven factors and Restrictions factors
The research report encompasses a comprehensive analysis of the factors that affect the growth of the market. It includes an evaluation of trends, restraints, and drivers that influence the market positively or negatively. The report also outlines the potential impact of different segments and applications on the market in the future. The information presented is based on historical milestones and current trends,โฆ
Depression-MDD Drugs Market Size, Share, Demand Forecast Report by 2030
Global Depression-MDD Drugs Market 2022-2028 - Global Industry Size, Supply Analysis, Price Analysis, Consumption and Production, Supplier and Cost Structure Analysis
Depression-MDD Drugs Market Overview
The recent market intelligence study by the research analysts at Market Business Insights (MBI) takes a deep dive into inner operations of the global Depression-MDD Drugs Market. It thoroughly examines the market landscape to give the readers an accurate insight into the current, as well as theโฆ
Major Depressive Disorder (MDD) - Drug Pipeline Landscape, 2022
Major Depressive Disorder (MDD) also known as clinical depression, is a severe mood disorder which causes persistent or extended periods of depressed or low mood, for more than 2 weeks and a loss of interest in activities thus affecting the mood and ability to function in daily life.
To know more about Major Depressive Disorder (MDD), visit - https://www.globalinsightservices.com/reports/major-depressive-disorder-mdd-drug-pipeline-landscape-2022/
The most common causes of Major Depressive Disorder include genetics, trauma, isolation,โฆ
U.S. Major Depressive Disorder (MDD) Market: Industry Analysis & Outlook (2018-2 โฆ
This report is available at 10% Discount for Single user License, 20% Discount for Corporate User License till 30 September 2018. To avail discount please contact at +1-888-391-5441 / sales@marketreportsonline.com.
Major Depressive Disorder Market (MDD) is a common mental illness characterized by persistent low mood that interferes with the personโs ability to eat, work, sleep and other activities. MDD is also referred to as clinical depression or recurrent depression.
Place aโฆ
MDD, Anxiety and Panic Disorder Therapeutics Market Trends and Forecast 2014 โ โฆ
The increasing prevalence of various psychological problems such as stress and sleeplessness is boosting the demand for MDD, anxiety, and panic disorder therapeutics. In its report, titled โMDD, Anxiety and Panic Disorder Therapeutics Market โ Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 โ 2020,โ Transparency Market Research (TMR) studies the various factors impacting the marketโs trajectory.
Download Exclusive Global Strategic Business Report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2928
Recent patent expiries did create aโฆ
